Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 6Completed 3Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

telitacicept 3rozanolixizumab 3talquetamab 1ravulizumab 1efgartigimod alfa 1blinatumomab 1Therapeutics 1Pyridostigmine Bromide 1Psychodrama 1Prednisone 1Population Groups 1Art Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Myasthenia Gravis × efgartigimod alfa × Clear all
NCT06221501 2024-01-24

Perioperative Efgartigimod for Thymoma and Myasthenia Gravis

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting
30 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡